Literature DB >> 2227940

Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu).

A Graham1, N A Kalsheker, F J Bamforth, C R Newton, A F Markham.   

Abstract

Two single point mutations in the alpha-1-antitrypsin gene, resulting in AAT deficiency, have been characterised in heterozygotes by DNA amplification and direct sequencing. The mutations result in amino acid substitutions, Gly115----Ser and Ser-19----Leu, in the leader sequence, respectively, and have been designated Pi Null(Newport) and Pi Z Wrexham. In the two families studied the mutations occur on chromosomes which also carry the common mutation causing Z deficiency. Individuals with such a deficiency are, therefore, compound heterozygotes. It is not known if these particular mutations would only cause a mild form of AAT deficiency in the absence of the Z mutation as they do not appear to cause predictable folding abnormalities. They do, however, result in severe deficiency when the Z mutation occurs in the same gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227940     DOI: 10.1007/bf00194233

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Characterisation of the alpha-1-antitrypsin M3 gene, a normal variant.

Authors:  A Graham; K Hayes; S Weidinger; C R Newton; A F Markham; N A Kalsheker
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys).

Authors:  A Graham; N A Kalsheker; C R Newton; F J Bamforth; S J Powell; A F Markham
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

3.  The serpins: evolution and adaptation in a family of protease inhibitors.

Authors:  R W Carrell; P A Pemberton; D R Boswell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

Review 4.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon.

Authors:  T Nukiwa; H Takahashi; M Brantly; M Courtney; R G Crystal
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

6.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

7.  Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene.

Authors:  T Nukiwa; K Satoh; M L Brantly; F Ogushi; G A Fells; M Courtney; R G Crystal
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

8.  Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity.

Authors:  F J Bamforth; N A Kalsheker
Journal:  J Med Genet       Date:  1988-02       Impact factor: 6.318

9.  Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes).

Authors:  D W Cox; H Levison
Journal:  Am Rev Respir Dis       Date:  1988-02

10.  Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon.

Authors:  K Satoh; T Nukiwa; M Brantly; R I Garver; M Hofker; M Courtney; R G Crystal
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

View more
  4 in total

1.  High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques.

Authors:  Xue Qin; Qiaopei Chen; Chun Sun; Cun Wang; Qiliu Peng; Li Xie; Yinkun Liu; Shan Li
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

Review 2.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

3.  Identification and characterisation of eight novel SERPINA1 Null mutations.

Authors:  Ilaria Ferrarotti; Tomás P Carroll; Stefania Ottaviani; Anna M Fra; Geraldine O'Brien; Kevin Molloy; Luciano Corda; Daniela Medicina; David R Curran; Noel G McElvaney; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

4.  Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid.

Authors:  Beatriz Lara; Maria Teresa Martínez; Ignacio Blanco; Cristina Hernández-Moro; Eladio A Velasco; Ilaria Ferrarotti; Francisco Rodriguez-Frias; Laura Perez; Irene Vazquez; Javier Alonso; Manuel Posada; Beatriz Martínez-Delgado
Journal:  Respir Res       Date:  2014-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.